Literature DB >> 19389113

Clinicovirologic analysis of hepatitis C infection in transfusion-dependent beta-thalassemia major children.

L Ragab1, S Helal, N Zaghloul, M El-Raziky, R Afifi, K M Musallam, A T Taher.   

Abstract

Regular blood transfusion puts beta-thalassemia major patients at a higher risk of developing hepatic iron overload and hepatitis C virus (HCV) infection. The association between several transfusion-related factors and an increased risk of developing HCV viremia has been reported. The effect of HCV infection on liver damage in transfusion-dependent thalassemia patients has been poorly described. A sample of 100 Egyptian transfusion-dependent beta-thalassemia major children were studied. Individual patients underwent full history taking, clinical examination and a panel of laboratory tests including HCV ribonucleic acid polymerase chain reaction (HCV-PCR) in blood samples. Liver biopsy was performed for 24 patients. HCV-PCR was positive in 64% of patients. A statistically significant correlation was found between HCV-PCR positivity (HCV viremia) and shorter inter-transfusion interval. There was a significant positive correlation between mean serum ferritin level and mean levels of alanine aminotransferase and aspartase aminotransferase. Histopathologic features of both chronic hepatitis and siderosis were present in 91.7% of biopsy specimens, and fibrosis was present in 41.67%. A higher risk of HCV viremia is noted with a shorter inter-transfusion interval. The reduced role of HCV infection in chronic liver injury in this group of patients may be surpassed by the associated effects of iron overload because of the chronic transfusion. However, the latter finding should be verified in larger studies.

Entities:  

Mesh:

Year:  2009        PMID: 19389113     DOI: 10.1111/j.1751-553X.2009.01155.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  5 in total

Review 1.  Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.

Authors:  Salah Mohamed El Sayed; Hussam Baghdadi; Ashraf Abou-Taleb; Hany Salah Mahmoud; Reham A Maria; Nagwa S Ahmed; Manal Mohamed Helmy Nabo
Journal:  J Blood Med       Date:  2014-10-30

2.  Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children.

Authors:  Magy S Abdelwahab; Mona S El-Raziky; Normine A Kaddah; Heba H Abou-Elew
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

3.  The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study.

Authors:  Sanaa Kamal; Sara Abdelhakam; Dalia Ghoraba; Mohamed Amer Mohsen; Ahmed Abdel Salam; Hoda Hassan; Leila Nabeigh
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

4.  Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major.

Authors:  Maria Musumeci; Vincenzo Caruso; Emilia Medulla; Venerando Torrisi; Roberta Migale; Silvia Angeletti; Salvatore Musumeci
Journal:  Dis Markers       Date:  2014-04-08       Impact factor: 3.434

5.  Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy.

Authors:  Ashraf Soliman; Mohamed Yassin; Fawzia Al Yafei; Lolwa Al-Naimi; Noora Almarri; Aml Sabt; Vincenzo De Sanctis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.